|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03359629 |
|
Date of registration:
|
23/11/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Spectrophon LTD Glucometry Monitor Accuracy
|
|
Scientific title:
|
Accuracy Evaluation of Glucometry Monitor Developed by Spectrophon LTD |
|
Date of first enrolment:
|
September 27, 2017 |
|
Target sample size:
|
210 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03359629 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Anatoly Kreinin, MD, PHD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Bruce Rappaport Medical Faculty, Technion, Haifa, Israel |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- must be between ages 18 and 75
- must be able to sign informed consent form.
Exclusion Criteria:
- Acute psychotic state
- Hepatitis
- HIV
- Tuberculosis
- Haemophilia and other serious coagulation disorders
- Significant impaired venous access
- Pregnancy
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Glucose Metabolism Disorders
|
|
Diabetes Mellitus
|
|
Intervention(s)
|
|
Device: YSI 2300 Stat Plus
|
|
Device: Spectrophon Glucometry Monitor
|
|
Primary Outcome(s)
|
|
Percentage of Measurements With < 15% Error
[Time Frame: 1-3 hours]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|